AI-resistant breast cancer cells show significant upregulation of the glutamine transporters SLC1A5 and GLS, and inhibition of MYC, SLC1A5, and GLS decrease cell proliferation in AI-resistant cells (119). This evidence concerns the gene MYC and breast carcinoma.